Evotec AG and IR Pharma have entered into an exclusive strategic alliance to provide integrated drug discovery solutions in the field of respiratory diseases. Financial terms were not disclosed. The alliance expands Evotec’s drug discovery platform into the area of respiratory diseases through IR Pharma’s expertise in in vitro and in vivo respiratory pharmacology. Also, Evotec is now able to offer fully integrated respiratory and inflammation focused drug discovery programs, from ta...